Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Harte Hanks (HHS) Cost of Revenue (2019 - 2025)

Harte Hanks has reported Cost of Revenue over the past 7 years, most recently at $11.7 million for Q4 2025.

  • Quarterly Cost of Revenue fell 20.8% to $11.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49.9 million through Dec 2025, down 11.91% year-over-year, with the annual reading at $49.9 million for FY2025, 11.91% down from the prior year.
  • Cost of Revenue was $11.7 million for Q4 2025 at Harte Hanks, roughly flat from $11.7 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $19.5 million in Q4 2022 and troughed at $11.3 million in Q1 2021.
  • The 5-year median for Cost of Revenue is $13.7 million (2024), against an average of $13.9 million.
  • Year-over-year, Cost of Revenue soared 35.73% in 2022 and then decreased 20.8% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $14.4 million in 2021, then soared by 35.73% to $19.5 million in 2022, then dropped by 15.98% to $16.4 million in 2023, then fell by 9.85% to $14.8 million in 2024, then dropped by 20.8% to $11.7 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Cost of Revenue are $11.7 million (Q4 2025), $11.7 million (Q3 2025), and $12.4 million (Q2 2025).